×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ACXP – acurx pharmaceuticals, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ACXP
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/17
11:37 am
acxp
Is Acurx Pharmaceuticals (ACXP) Outperforming Other Medical Stocks This Year? [Yahoo! Finance]
Medium
Report
Is Acurx Pharmaceuticals (ACXP) Outperforming Other Medical Stocks This Year? [Yahoo! Finance]
3/13
01:03 pm
acxp
Acurx Pharmaceuticals, Inc. (ACXP) Q4 2025 Earnings Call Transcript [Seeking Alpha]
Medium
Report
Acurx Pharmaceuticals, Inc. (ACXP) Q4 2025 Earnings Call Transcript [Seeking Alpha]
3/13
07:01 am
acxp
Acurx Pharmaceuticals, Inc. Reports Full Year and Fourth Quarter Results and Provides Business Update
High
Report
Acurx Pharmaceuticals, Inc. Reports Full Year and Fourth Quarter Results and Provides Business Update
3/11
03:52 pm
acxp
Acurx Pharmaceuticals, Inc. [CNN]
Low
Report
Acurx Pharmaceuticals, Inc. [CNN]
3/9
08:10 am
acxp
Acurx Announces New Ibezapolstat Clinical Trial Program in Patients with Recurrent CDI That Has the Potential to Shift the Paradigm of Treatment and Prevention of C. difficile Infection [Yahoo! Finance]
High
Report
Acurx Announces New Ibezapolstat Clinical Trial Program in Patients with Recurrent CDI That Has the Potential to Shift the Paradigm of Treatment and Prevention of C. difficile Infection [Yahoo! Finance]
3/9
08:01 am
acxp
Acurx Announces New Ibezapolstat Clinical Trial Program in Patients with Recurrent CDI That Has the Potential to Shift the Paradigm of Treatment and Prevention of C. difficile Infection
High
Report
Acurx Announces New Ibezapolstat Clinical Trial Program in Patients with Recurrent CDI That Has the Potential to Shift the Paradigm of Treatment and Prevention of C. difficile Infection
2/24
01:29 pm
acxp
Acurx Pharmaceuticals (ACXP) Secures New US Patent for DNA Polymerase IIIC Inhibitors [Yahoo! Finance]
Low
Report
Acurx Pharmaceuticals (ACXP) Secures New US Patent for DNA Polymerase IIIC Inhibitors [Yahoo! Finance]
2/16
08:10 am
acxp
Acurx Pharmaceuticals to Discuss Full Year and Fourth Quarter 2025 Financial Results on March 13, 2026 Conference Call and Provide Business Update [Yahoo! Finance]
Low
Report
Acurx Pharmaceuticals to Discuss Full Year and Fourth Quarter 2025 Financial Results on March 13, 2026 Conference Call and Provide Business Update [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
3/13/2026
07:01 am
ACXP
acurx pharmaceuticals, inc.
BEAT
Report
-22.2%
acurx pharmaceuticals, inc.
11/12/2025
07:01 am
ACXP
acurx pharmaceuticals, inc.
BEAT
Report
-12.3%
acurx pharmaceuticals, inc.
8/12/2025
07:01 am
ACXP
acurx pharmaceuticals, inc.
BEAT
Report
-4.0%
acurx pharmaceuticals, inc.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/12
04:17 pm
acxp
Form S-8 Acurx Pharmaceuticals,
High
Report
Form S-8 Acurx Pharmaceuticals,
3/12
04:07 pm
acxp
Form 10-K Acurx Pharmaceuticals, For: Dec 31
High
Report
Form 10-K Acurx Pharmaceuticals, For: Dec 31
3/9
09:00 am
acxp
Form 8-K Acurx Pharmaceuticals, For: Mar 09
High
Report
Form 8-K Acurx Pharmaceuticals, For: Mar 09
2/12
06:05 am
acxp
Form EFFECT Acurx Pharmaceuticals,
High
Report
Form EFFECT Acurx Pharmaceuticals,
2/11
04:22 pm
acxp
Form 424B3 Acurx Pharmaceuticals,
Medium
Report
Form 424B3 Acurx Pharmaceuticals,
2/2
04:48 pm
acxp
Form S-1 Acurx Pharmaceuticals,
Medium
Report
Form S-1 Acurx Pharmaceuticals,
1/7
06:02 am
acxp
Form EFFECT Acurx Pharmaceuticals,
Low
Report
Form EFFECT Acurx Pharmaceuticals,
12/30
04:01 pm
acxp
Form S-3/A Acurx Pharmaceuticals,
Medium
Report
Form S-3/A Acurx Pharmaceuticals,
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: